On February 17, 2017, Robert N. Weingarten informed the Board of Directors of RespireRx Pharmaceuticals Inc. that he had decided to resign as a director, Vice President and Chief Financial Officer of the company. Mr. Weingarten indicated that his resignation was for personal reasons, and the company does not believe the resignation was the result of any disagreement with the company on any matter relating to the Company's operations, policies or practices. The Board of Directors, acting by written consent on February 22, 2017, appointed Jeff E. Margolis, the company's Vice president, Treasurer and Secretary, to act as the company's interim Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 USD | -4.76% | -39.39% | +122.22% |
1st Jan change | Capi. | |
---|---|---|
+122.22% | 1.61M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.73% | 22.78B | |
-10.67% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- RSPI Stock
- News RespireRx Pharmaceuticals Inc.
- RespireRx Pharmaceuticals Inc. Announces Management Changes